Analyses of apoptotic regulators CASP9 and DFFA at 1p36.2, reveal rare allele variants in human neuroblastoma tumours

被引:36
作者
Abel, F [1 ]
Sjöberg, RM [1 ]
Ejeskär, K [1 ]
Krona, C [1 ]
Martinsson, T [1 ]
机构
[1] Sahlgrens Univ Hosp E, Univ Gothenburg, Dept Clin Genet, S-41685 Gothenburg, Sweden
关键词
1p-deletion; neuroblastoma; neuroectodermal; Apaf-3; DFF; ICAD;
D O I
10.1038/sj.bjc.6600111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The genes encoding Caspase-9 and DFF45 have both recently been mapped to chromosome region 1p36.2, that is a region alleged to involve one or several tumour suppressor genes in neuroblastoma tumours. This study presents an update contig of the 'Smallest Region of Overlap of deletions' in Scandinavian neuroblastoma tumours and suggests that DFF45 is localized in the region. The genomic organization of the human DFF45 gene, deduced by in-silico comparsons of DNA sequences, Ts described for the first time in this paper. In the present study 44 primary tumours were screened for mutation by-analysis of the genomic sequences of the genes. In two out of the 44 tumours this detected in the DFFA gene one rare allele variant that caused a non-polar to a polar amino acid exchange in a preserved hydrophobic patch of DFF45. One case was hemizygous due to deletion of the more common allele of this polymorphism, Out of 194 normal control alleles only one was found to carry this variant allele, so in respect of it, no healthy control individual out of 97 was homozygous. Moreover, our RT-PCR expression studies showed that DFF45 is preferably expressed in low-stage neuroblastoma tumours and to a lesser degree in high-stage neuroblastomas, We conclude that although coding mutations of Caspase-9 and DFF45 are infrequent in neuroblastoma tumours, our discovery of a rare allele in two neuroblastoma cases should be taken to war-ant further studies of the role of DFF45 in neuroblastoma genetics. (C) 2002 Cancer Research UK.
引用
收藏
页码:596 / 604
页数:9
相关论文
共 44 条
  • [1] Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
    Abel, F
    Ejeskär, K
    Kogner, P
    Martinsson, T
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (08) : 1402 - 1409
  • [2] Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
    Bown, N
    Cotterill, S
    Lastowska, M
    O'Neill, S
    Pearson, ADJ
    Plantaz, D
    Meddeb, M
    Danglot, G
    Brinkschmidt, C
    Christiansen, H
    Laureys, G
    Speleman, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) : 1954 - 1961
  • [3] REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT
    BRODEUR, GM
    PRITCHARD, J
    BERTHOLD, F
    CARLSEN, NLT
    CASTEL, V
    CASTLEBERRY, RP
    DEBERNARDI, B
    EVANS, AE
    FAVROT, M
    HEDBORG, F
    KANEKO, M
    KEMSHEAD, J
    LAMPERT, F
    LEE, REJ
    LOOK, AT
    PEARSON, ADJ
    PHILIP, T
    ROALD, B
    SAWADA, T
    SEEGER, RC
    TSUCHIDA, Y
    VOUTE, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) : 1466 - 1477
  • [4] BRODEUR GM, 1990, CANCER SURV, V9, P673
  • [5] Regulation of cell death protease caspase-9 by phosphorylation
    Cardone, MH
    Roy, N
    Stennicke, HR
    Salvesen, GS
    Franke, TF
    Stanbridge, E
    Frisch, S
    Reed, JC
    [J]. SCIENCE, 1998, 282 (5392) : 1318 - 1321
  • [6] EVIDENCE FOR 2 TUMOR-SUPPRESSOR LOCI ON CHROMOSOMAL BANDS-1P35-36 INVOLVED IN NEUROBLASTOMA - ONE PROBABLY IMPRINTED, ANOTHER ASSOCIATED WITH N-MYC AMPLIFICATION
    CARON, H
    PETER, M
    VANSLUIS, P
    SPELEMAN, F
    DEKRAKER, J
    LAUREYS, G
    MICHON, J
    BRUGIERES, L
    VOUTE, PA
    WESTERVELD, A
    SLATER, R
    DELATTRE, O
    VERSTEEG, R
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (04) : 535 - 539
  • [7] Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors
    Ejeskär, K
    Abel, F
    Sjöberg, RM
    Bäckström, J
    Kogner, P
    Martinsson, T
    [J]. CYTOGENETICS AND CELL GENETICS, 2000, 89 (1-2): : 62 - 66
  • [8] Ejeskär K, 1999, INT J MOL MED, V3, P585
  • [9] Ejeskär K, 2001, MED PEDIATR ONCOL, V36, P61, DOI 10.1002/1096-911X(20010101)36:1<61::AID-MPO1016>3.0.CO
  • [10] 2-0